(Q37189879)

18 August 2017

Prior authorization for antidepressants in Medicaid: effects among disabled dual enrollees (English)

1 reference

18 August 2017

0 references

5

Dennis Ross-Degnan

1 reference

18 August 2017

1

Alyce S Adams

1 reference

18 August 2017

10

Stephen B Soumerai

1 reference

18 August 2017

Fang Zhang

2

1 reference

18 August 2017

Robert F LeCates

3

1 reference

18 August 2017

Amy Johnson Graves

4

1 reference

18 August 2017

Daniel Gilden

6

1 reference

18 August 2017

Thomas J McLaughlin

7

1 reference

18 August 2017

Christine Lu

8

1 reference

18 August 2017

Connie M Trinacty

9

1 reference

18 August 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

18 August 2017

JAMA Internal Medicine

1 reference

18 August 2017

169

1 reference

18 August 2017

8

1 reference

18 August 2017

750-756

1 reference

Use of atypical antipsychotic drugs for schizophrenia in Maine Medicaid following a policy change.

18 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Paroxetine versus placebo and other agents for depressive disorders: a systematic review and meta-analysis

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Antiepileptic drugs in non-epilepsy disorders: relations between mechanisms of action and clinical efficacy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

The CATIE schizophrenia trial: results, impact, controversy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Coverage and prior authorization of psychotropic drugs under Medicare Part D.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Efficacy and safety of second-generation antidepressants in the treatment of major depressive disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Medicaid policies to contain psychiatric drug costs

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

A retrospective analysis of the revocation of prior authorization restrictions and the use of antidepressant medications for treating major depressive disorder

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Effects of restrictive formularies in the ambulatory care setting

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Performance of comorbidity scores to control for confounding in epidemiologic studies using claims data

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Effect of mental health specialty care on antidepressant length of therapy

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Cost-effectiveness of antidepressant medications

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Payment restrictions for prescription drugs under Medicaid. Effects on therapy, cost, and equity.

14 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Medicare Part D prescription drug benefits and administrative burden in the care of dually eligible psychiatric patients

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

Estimating Medicare Part D's impact on medication access among dually eligible beneficiaries with mental disorders.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression.

3 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2681242

SSRI antidepressant drug use patterns in the naturalistic setting: a multivariate analysis

3 September 2018

1 reference

12 December 2020

Segmented regression analysis of interrupted time series studies in medication use research

1 reference

12 December 2020

Analysis of interrupted time series mortality trends: an example to evaluate regionalized perinatal care

1 reference

12 December 2020

Benefits and Consequences for the Poor and the Disabled

1 reference

12 December 2020

10.1001/ARCHINTERNMED.2009.39

Identifiers

DOI

1 reference

18 August 2017

1 reference

18 August 2017

PubMed publication ID

19398686

1 reference